Next-Gen Cell-Penetrating Antibodies for Tumor Targeting and RAD51 Inhibition
October 21, 2024
“Overall, the data presented in this study affirm that humanizing 3E10 preserves its crucial biological properties essential for therapeutic efficacy.” BUFFALO, NY- October 21, 2024 – A new research paper… read more